Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation

Virology

Volumn 228, Issue 2, 1997, Pages 244-250

  Kawanishi, Michiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; ELECTROPORATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 0031575527     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8370     Document Type: Article

References (33)

1. Armstrong A. A., Gallagher A., Krajewski A. S.et al. The expression of the EBV latent membrane (LMP1) is independent of CD23 andbcl-2. Histopathology. 21:1992;72-73.
2. Balchwal V. R., Sugden B. Transformation of Balb 3T3 cells by the BNLF1 gene of Epstein-Barr virus. Oncogene. 2:1988;461-467.
3. Bhagat S. K. M., Medeiros L. J., Weiss L. M., Wang J., Raffelt M., Stetler-Stevenson M. bcl-2. Am. J. Clin. Pathol. 99:1993;604-608.
4. Chen C., Sadler R. H., Walling D. M., Su I., Hsieh H., Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphoma. J. Virol. 67:1993;6303-6308.
5. Cherney B. W., Bhatia K., Tosato G. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA. 91:1994;12967-12971.
6. Cleary M. L., Dorfman R. F., Sklar J. Failure in immunological control of the virus infection: Post-transplant lymphomas. The Epstein-Barr Virus: Recent Advances. 1986;Heinemann, London. p. 163-181.
7. Dowson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature (London). 344:1990;777-780.
8. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
9. Fåhraeus R., LiFu H., Ernberg I., Finke J., Rowe M., Klein G., Falk K., Nilsson E., Yadav M., Busson P., Tursz T., Kallin B. Expression of Epstein-Barr virus proteins in nasopharyngeal carcinoma. Int. J. Cancer. 42:1988;329-338.
10. Hammerschmidt W., Sugden B., Baichwal V. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:1989;2467-2475.
11. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction ofbcl-2. Cell. 65:1991;1107-1115.
12. Kawanishi M., Sugawara K., Ito Y. Epstein-Barr virus-induced polypeptides: A comparative study with superinfected Raji, IUdR-treated, andn. Virology. 109:1981;72-81.
13. Kawanishi M. Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection. J. Virol. 67:1993;7654-7658.
14. Khan G., Coates P. J. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J. Pathol. 174:1994;141-149.
15. Khan G., Gupta R. K., Coates P. J., Slavin G. Epstein-Barr virus infection andbcl-2. Am. J. Pathol. 143:1993;1270-1274.
16. Kieff E., Liebowitz D. The Epstein-Barr virus. Fields B., Knipe D. Virology. 1989;1889-1920 Raven Press, New York.
17. Klein G. The relationship of the virus to nasopharyngeal carcinoma. Epstein M. A., Achong B. The Epstein-Barr Virus. 1979;340-350 Springer-Verlag, Berlin.
18. Laherty C. D., Hu H. M., Opipai A. W., Wang F., Dixit V. M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J. Biol. Chem. 267:1992;24157-24160.
19. Lenoir G. M. Role of the virus, chromosomal translocations and cellular oncogenes in the aetiology of Burkitt's lymphoma. Epstein M. A., Achong B. C. The Epstein-Barr Virus: Recent Advances. 1986;183-205 Heinemann, London.
20. Li-Fu H., Minarovits J., Shi-Long C., Contreras-Salazar B., Rymo L., Falk K., Klein G., Ernberg I. Variable expression of laten membrane protein in nasopharyngeal carcinoma can be related to methylatin status of the Epstein-Barr virus BNLF-1 5′-flanking region. J. Virol. 65:1991;1558-1567.
21. Martin J. M., Veis D., Korsmeyer S. J., Sugden B. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol. 67:1993;5269-5278.
22. Miller W. E., Earp H. S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 69:1995;4390-4398.
23. Pallesen G., Hamilton-Dutoit S. J., Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: Two new developments in the EBV field. Adv. Cancer Res. 62:1993;179-239.
24. Rowe M., Peng-Pilon M., Huen D. S., Hardy R., Croom-Carter D., Lundgren E., Rickinson A. B. Upregulation ofbcl-2. J. Virol. 68:1994;5602-5612.
25. Sarma V., Lin Z., Clark L., Rust B. M., Tewari M., Noelle R. J., Dixit V. M. Activation of the B-cell surface receptor CD40 induces A20, a novel Zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:1995;12343-12346.
26. Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P., Green D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:1992;212-214.
27. Tsujimoto Y. Overexpression of the human BCL-2 gene protect results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA. 86:1989;1958-1962.
28. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:1985;831-840.
29. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J. Virol. 62:1988;4173-4184.
30. Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effecters of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:1990;2309-2318.
31. Yin X-M., Oltvai Z. N., Korsmeryer S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
32. Young L., Dawson C., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A. B. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 69:1988;1051-1065.
33. Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson K. C., Ritz J., Shapiro R. S., Rickinson A., Kieff E., Cohen J. I. Epstein-Barr virus transformation associated genes are expressed in tissues from patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1989;1080-1085.